Jiangsu Recbio Technology Co (HKSE:02179) Accounts Payable & Accrued Expense : HK$242.34 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Recbio Technology Co Accounts Payable & Accrued Expense?

Jiangsu Recbio Technology Co's quarterly accounts payable & accrued expense increased from Jun. 2023 (HK$180.22 Mil) to Dec. 2023 (HK$228.04 Mil) and increased from Dec. 2023 (HK$228.04 Mil) to Jun. 2024 (HK$242.34 Mil).

Jiangsu Recbio Technology Co's annual accounts payable & accrued expense increased from Dec. 2021 (HK$66.62 Mil) to Dec. 2022 (HK$185.73 Mil) and increased from Dec. 2022 (HK$185.73 Mil) to Dec. 2023 (HK$228.04 Mil).

Jiangsu Recbio Technology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jiangsu Recbio Technology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Recbio Technology Co Accounts Payable & Accrued Expense Chart

Jiangsu Recbio Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

14.49

20.74

66.62

185.73

228.04

Jiangsu Recbio Technology Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial				82.40	185.73	180.22	228.04	242.34

Jiangsu Recbio Technology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jiangsu Recbio Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Recbio Technology Co Ltd (HKSE:02179) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

G93:Germany

Address

No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN

Website

https://www.recbio.cn

Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Executives

Feng Tao	2201 Interest of corporation controlled by you
Bei Jing Jun Lian Cheng Yuan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Zhu Linan	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Jun Cheng He Zhong Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Jun Lian Jie You Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hui Zhi Yi Hao Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Chen Hao	2201 Interest of corporation controlled by you
La Sa Jun Qi Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Shang Hai Chao Rui Yi Yao Ke Ji He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Lyfe Capital Fund Iii (dragon), L.p.
Liu Yong
Chen Wei	2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you

Jiangsu Recbio Technology Co Headlines

No Headlines